NFCR-Supported Research Team Working On CAR-T Immunotherapy For Pancreatic Cancer
[vc_row][vc_column][vc_video link="https://www.youtube.com/watch?v=5xkfbQKugxY&t"][vc_column_text]Pancreatic cancer is one of the most lethal malignancies with few treatment options. Its five-year survival rate is only about 10% in the US. Several treatment options are available for pancreatic cancers, including surgery, chemotherapy, radiation therapy, immunotherapy, and combinational therapies. However, these therapies...